Fundraising FoxRETHAM TECHNOLOGIES LLC
Wauwatosa, US · Founded 2024
Find your way into RETHAM TECHNOLOGIES LLC
Sign up to see every warm intro you have to RETHAM TECHNOLOGIES LLC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RETHAM TECHNOLOGIES LLC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Retham Technologies develops diagnostic assays for heparin-induced thrombocytopenia (HIT) and related blood disorders. The company serves clinical laboratories and healthcare systems with in vitro diagnostic tests.
Founders & leadership
VS
Visuri StevenExecutive
Board
CJ
Curtis JonesBoard director
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2026
▶$1.1MraisedSep 2026 · 6 investors · OtherRule 506(b)
▶$1.1MraisedSep 2026 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Visuri StevenExecutive Officer, Director
- Curtis JonesDirector
- Anand PadmanabhanDirector
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does RETHAM TECHNOLOGIES LLC do?
- Retham Technologies develops diagnostic assays for heparin-induced thrombocytopenia (HIT) and related blood disorders. The company serves clinical laboratories and healthcare systems with in vitro diagnostic tests.
- How much funding has RETHAM TECHNOLOGIES LLC raised?
- RETHAM TECHNOLOGIES LLC has disclosed $1.1M raised across 1 round.
- Where is RETHAM TECHNOLOGIES LLC headquartered?
- RETHAM TECHNOLOGIES LLC is headquartered in Wauwatosa, US.